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The need for consistent and current data describing the true incidence of sudden cardiac arrest (SCA) and/or sudden
cardiac death (SCD) was highlighted during the most recent Sudden Cardiac Arrest Thought Leadership Alliance’s
(SCATLA) Think Tank meeting of national experts with broad representation of key stakeholders, including thought
leaders and representatives from the American College of Cardiology, American Heart Association, and the Heart
Rhythm Society. As such, to evaluate the true magnitude of this public health problem, we performed a systematic
literature search in MEDLINE using the MeSH headings, “death, sudden” OR the terms “sudden cardiac death” OR
“sudden cardiac arrest” OR “cardiac arrest” OR “cardiac death” OR “sudden death” OR “arrhythmic death.” Study se-
lection criteria included peer-reviewed publications of primary data used to estimate SCD incidence in the U.S. We
used Web of Science’s Cited Reference Search to evaluate the impact of each primary estimate on the medical litera-
ture by determining the number of times each “primary source” has been cited. The estimated U.S. annual incidence
of SCD varied widely from 180,000 to 450,000 among 6 included studies. These different estimates were in part
due to different data sources (with data age ranging from 1980 to 2007), definitions of SCD, case ascertainment cri-
teria, methods of estimation/extrapolation, and sources of case ascertainment. The true incidence of SCA and/or
SCD in the U.S. remains unclear, with a wide range in the available estimates that are badly dated. As reliable esti-
mates of SCD incidence are important for improving risk stratification and prevention, future efforts are clearly
needed to establish uniform definitions of SCA and SCD and then to prospectively and precisely capture cases of SCA
and SCD in the overall U.S. population. (J Am Coll Cardiol 2011;57:794–801) © 2011 by the American College of
Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.09.064In the U.S., cardiovascular disease was the underlying cause
of 1 of every 2.9 deaths occurring in 2006 (1). The
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accepted September 27, 2010.proportion of these deaths that is sudden has been estimated
to be as high as 50%, making sudden cardiac death (SCD)
the most common cause of death in this country (2). Studies
are available that provide consistent data on survival after
sudden cardiac arrest (SCA) (3,4), and several randomized
controlled trials offer reliable information on therapies for
the prevention of SCD in highly selected, high-risk sub-
groups (5–11). Nevertheless, data describing the incidence
of SCA and/or SCD in the overall U.S. population appear
to be inconsistent, making it difficult to determine the actual
magnitude of this problem. Published estimates of SCA
and/or SCD incidence in the U.S. vary widely depending on
the source (12). Another major issue limiting the ability to
determine the true magnitude of SCD is the lack of
consensus on its definition and appropriate designation. Not
only are SCD and SCA often used interchangeably despite
having 2 distinct definitions, an agreement on the best
definition for these entities is yet to be reached. Subtleties
inherent in these clinical definitions have far-reaching
public health implications, as they affect the ability to
meaningfully discuss these clinical outcomes, and reach any
conclusions about their magnitude.
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true incidence of SCA and/or SCD was highlighted during
the most recent Sudden Cardiac Arrest Thought Leader-
ship Alliance’s (SCATLA) Think Tank meeting in Wash-
ington, DC, which convened a group of national experts
with broad representation of key stakeholders including
thought leaders and representatives from the American Col-
lege of Cardiology (ACC), American Heart Association
(AHA), and the Heart Rhythm Society (13). As a result, in
this study, we systematically evaluate the sources of the wide
range of published estimates for the incidence of SCA and/or
SCD. In addition, we propose recommendations to facilitate a
more reliable estimation of SCA and/or SCD incidence, which
will advance our knowledge and the development of public
awareness, education, and prevention.
Methods
To find estimates of the incidence of SCA and/or SCD, a
systematic literature search was performed in MEDLINE
using the MeSH headings, “death, sudden” OR “death,
sudden, cardiac” or the terms “sudden cardiac death” OR
Figure 1 Systematic Literature Review Search Flow Diagram
ACS  acute coronary syndrome; CPR  cardiopulmonary resuscitation; ECG  el
HF  heart failure; HL  hyperlipidemia; HTN  hypertension; SCA  sudden card“sudden cardiac arrest” OR “car-
diac arrest” OR “cardiac death”
OR “sudden death” OR “ar-
rhythmic death.” Study selection
criteria included peer-reviewed
publications of primary data used
to estimate the incidence of SCD
in the U.S. Studies that did not
report primary data and/or were
not performed in a U.S. popula-
tion were excluded.
Of the 13,649 abstracts that
resulted from the comprehensive
search strategy, the vast majority
were excluded for the reasons
detailed in Figure 1. Thirty-five full-length, peer-reviewed,
publications were selected for full review, which yielded 6
studies providing primary data used to derive an estimated
annual incidence of SCD in the U.S. (14–19). The study by
Chugh et al. (17) published in 2004 provides primary data
for a count estimate of SCD; however, an estimated annual
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subsequent paper published by Chugh et al. (20) in 2008. As
such, we included the 2004 study and cited additional data
from the 2008 study. Review of expert consensus documents
including the ACC/AHA/European Society of Cardiology
(ESC) 2006 Guidelines for Management of Patients with
Ventricular Arrhythmias and the Prevention of Sudden
Cardiac Death and bibliographies identified 2 additional
sources for the estimate of the incidence of SCA and/or
SCD; however, both were excluded owing to lack of primary
data (2,21). Given the wide range of estimated incidences of
SCA and/or SCD cited in the literature despite the small
number of primary sources providing such estimates, to
obtain a sense of the degree of data dissemination in the
medical literature we used the Web of Science’s Cited
Reference Search tool to determine the number of times
each of these “primary sources” has been cited.
Results
Estimates of SCA and/or SCD incidence. Despite a very
broad search strategy, only 6 publications have reported
estimates of the incidence of SCA and/or SCD in the U.S.
derived from primary data (Table 1) (14–19). Estimations
of SCA and/or SCD incidence ranged widely from 180,000
to 450,000 (17,18). The oldest study was published in
1989, using National Center for Health Statistics (NCHS)
and death certificate data from 1980 to 1985 (14). The most
recent study was published in 2008 using data collected
between May 1, 2006, and April 30, 2007, from 10 North
American sites (8 U.S. sites) that was subsequently extrap-
olated to the U.S. population (19).
Methods of estimation differed among studies. Two
studies extrapolated estimates of national annual incidence
of SCA and/or SCD based on smaller community-based
studies (16,17). One study used registry data from 8
different sites in the U.S. to extrapolate a national annual
incidence (19). The 3 remaining studies used national level
data to provide estimates (14,15,18); however, 1 of these
studies reported only data from the 40 states that reported
data to the NCHS (14).
Differences in definitions. The stated definitions of SCA
nd/or SCD varied across the 6 studies (Table 1). Three
tudies included time constraints in their case definitions for
CD (15,17,18). Four sources included a geographical
ocation of the event as part of the case definition
14,16,18,19). Although 2 studies specifically defined SCD
s death attributable to ischemic or coronary heart disease
14,15), the other studies broadened their criteria to include
eath from a cardiac or cardiovascular etiology (16–19).
ne study included “survivors of cardiac arrest” in their case
efinition of SCD (17), and the most recent study also
pecifically examined out-of-hospital cardiac arrest and
ncluded deaths as well as patients who survived to hospital
ischarge (19).
ifferences in case ascertainment. Reflecting the varia-tion in definitions of SCA and SCD among these primarysources, the derivation methodologies for each study were
also different (Table 2) (22). The age cut-offs for the studied
populations were highly variable. Two studies used an age
cut-off of 25 years (14,15); 1 study used an age cut-off of
35 years (18); and another study used age 20 years (16).
The 2 most recent studies did not specify any age criteria
(17,19).
Five studies used death certificate data in addition to
other survey or report data including the NCHS, the National
Mortality Followback Survey, U.S. Bureau of the Census data,
and emergency medical services reports (14–18). In contrast,
the study by Nichol et al. (19) assesses out-of-hospital cardiac
arrest incidence and outcomes and did not use death certifi-
cates to determine mortality, but used case-fatality rates from a
registry. When vital status data were missing, the authors used
multiple imputation methods to determine mortality rates (19).
Only 2 studies used prospective case ascertainment (17,19).
Dissemination of data from primary sources. Despite the
markedly heterogeneous SCA and/or SCD equivalent def-
initions and methods of estimation, all of these papers have
been cited as sources of estimates for the incidence of SCA
and/or SCD in the U.S. Four of the 6 source papers
identified by our MEDLINE search were also referenced in
the ACC/AHA/ESC 2006 guidelines (12,14–16,18); how-
ever, the guidelines cited 2 additional studies as primary
data sources for the wide ranging estimates of SCD inci-
dence in the U.S. (Table 3) (21,23,24). As these citations
were selected by the Writing Committee to Develop Guide-
lines for Management of Patients with Ventricular Arrhyth-
mias and the Prevention of Sudden Cardiac Death, they
represent expert consensus on the best source documents
providing information on the incidence of SCA and/or
SCD. The oldest reference was published in 1989 (14), and
the most current source was published in 2004 (21);
however, 2 of the sources cited by the guidelines were not
primary derivations of the estimated incidence of SCA
and/or SCD (2,21).
These documents have been widely cited in the published
body of peer-reviewed literature (Table 4). The most often
cited source was published almost a decade ago using U.S.
vital statistics and death certificate data from 1989 to 1998
(18), but has been cited 400 times from March 2002—most
recently in November 2009. The next most cited source was
published in 1993 and does not provide primary data from
which an estimated incidence of SCD was derived, but
instead states that “estimates are based on published epide-
miologic and clinical data” (2). Finally, the third most often
cited source was published in 1989 and was based on death
certificates and data from the NCHS collected from 1980 to
1985—30 years ago (14).
Discussion
There are 2 main findings for this study: 1) definitions of
SCA and SCD are not standardized across the medical
Published Estimates of Annual Incidence of SCD in the U.S.Table 1 Published Estimates of Annual Incidence of SCD in the U.S.
Source (Ref. #) Definitional Equivalents of SCA or SCD
Estimated Annual
Incidence of SCD
Proportion of
Sudden Deaths
Considered SCD Method of Estimation
Dates Data Collected for
Estimate
Publication
Date
Gillum (14) SCD  sudden coronary death, defined as deaths attributed
to ischemic heart disease occurring out of hospital or in
ERs.
223,864 56% Based on national level data
(from 40 states)
1980–1985 1989
Escobedo et al. (15) SCD  sudden coronary death, defined as CHD deaths of
persons dying within 1 h of onset of cardiovascular
symptoms.
251,000 48% Based on national level data
(except Oregon)
1980 and 1986 1996
Zheng et al. (18) SCD  sudden cardiac death, defined as the sudden,
unexpected natural death from cardiac cause a short
time (generally 1 h) after onset of symptoms in a
person without any previous condition that would seem
fatal, or any cardiac death occurring out of hospital or
taking place in the ER or dead on arrival in the ER.
456,076 63.3% Based on national level data 1989–1998 2001
Cobb et al. (16) All cardiac arrest cases with presumed cardiac etiology who
received advanced life support from Seattle Fire
Department EMS.
184,000 NR Extrapolated from community
study (Seattle, WA)
During specified periods
between 1979 and 2000
2002
Chugh et al.,
2004 (17) and
Chugh et al.,
2008 (20)*
SCD  sudden cardiac death, defined using the WHO
criteria as sudden unexpected death either within 1 h of
symptom onset (event witnessed), or within 24 h of
having been observed alive and symptom free
(unwitnessed). Survivors of cardiac arrest were also
included under SCD cases.
180,000–250,000 NR Extrapolated from community
study (Multnomah County, OR)
2002–2003 2004,
2008
Nichol et al. (19) Cardiac arrest cases that occurred outside the hospital,
were evaluated by EMS, and either: 1) received attempts
at external defibrillation or chest compressions by
organized EMS, or 2) were pulseless but did not receive
CPR or attempts to defibrillate by EMS.
294,851 (quasi-CI:
236,063–325,007)
NR Extrapolated from 8 U.S. sites
(Alabama; Iowa; Dallas, TX;
Milwaukee, WI; Pittsburgh, PA;
Portland, OR; San Diego, CA;†
Seattle, WA)
2006–2007 2008
*A count estimate is not provided in Chugh et al., 2004, but is extrapolated and reported in Chugh et al., 2008. †The San Diego, California, site self-reported incomplete case capture and was thus excluded from the analyses published by Nichol et al. (19).
CHD coronary heart disease; CI confidence interval; CPR cardiopulmonary resuscitation; EMS emergency medical services; ER emergency room; NR not reported; SCA sudden cardiac arrest; SCD sudden cardiac death; WHOWorld Health Organization.
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Case Ascertainment Criteria and SourcesTable 2 Case Ascertainment Criteria and Sources
Source (Ref. #)
Case Ascertainment Criteria
Sources for Case AscertainmentTime Geography
Disease
Attribution
Witnessed or
Unwitnessed Age
SCA
Included
Gillum (14) Not specified Out of hospital or in ER Ischemic heart
disease
Not specified 25 yrs No 1. NCHS data from 40 states that reported data
2. U.S. standard certificate of death, item 7c*
Escobedo et al. (15) 1 h of onset of
cardiovascular
symptoms
Not specified Coronary heart
disease
Not specified 25 yrs No 1. 1986 National Mortality Followback Survey (did not include
data from Oregon or patients 25 yrs of age)†
2. 1980 U.S. Bureau of the Census data
3. Death certificates (death considered to have resulted from
CHD if death certificate listed ICD-9 codes 410–414)
4. Additional information obtained through questionnaire/
interview of person identified as the informant on death
certificate (89% of informants responded)
Zheng et al. (18) 1 h of symptoms Out of hospital or in ER
or “dead on arrival”
with cause of death
reported as cardiac
disease
Cardiac disease
death
Not specified 35 yrs No 1. NCHS data
2. Death certificates (death considered to have resulted from
cardiac disease if underlying cause of death classified
using ICD-9 codes 390–398, 402, or 404–429)
Cobb et al. (16) Not specified Out of hospital Cardiac cause Witnessed or
unwitnessed
20 yrs No 1. Medical incident reports submitted by fire department
paramedics for all patients who received advanced life
support by Seattle Fire Department/EMS personnel
2. Any missing data from above obtained from death
certificates or hospital admission forms*
Chugh et al., 2004 (17)
and Chugh et al.,
2008 (20)
1 h of symptoms if
witnessed, or 24 h
if unwitnessed
Not specified Cardiac cause Witnessed or
unwitnessed
No age criteria Yes 1. Case ascertainment from EMS system (78%), county
medical examiner’s office (20%), and 16 area hospitals
(2%). Of 353 cases, 280 identified by EMS, 68 by medical
examiner, and 5 by hospital or provider
2. Post-mortem examination performed at discretion of
medical examiner or physician
3. Death certificate data from Oregon State Health Division
4. Available medical records
Nichol et al. (19) Not specified Out of hospital Cardiac cause Not specified No age criteria (infants,
children, adults all
included)
Yes 1. ROC, a clinical research network of 11 sites and 1 central
coordinating center, conducts clinical research on
cardiopulmonary arrest and traumatic injury. The ROC
registry, ROC Epistry-Cardiac Arrest, is a prospective,
multicenter, observational registry of out-of-hospital arrests
in EMS agencies and 11 institutions (8 U.S., 3 Canada)
2. Multiple case ascertainment strategies used: telephone
notification of each incident defibrillator use or CPR by
EMS, hand sorting of paper EMS charts, electronic queries
of EMS records using various data fields such as dispatch
type, vital signs, or diagnosis
*Percent of data from each source not provided. †The National Mortality Followback Survey is described as a random sample of 1% of U.S. resident deaths (except residents of Oregon) age 25 years or older in 1986 (22).
ICD-9  International Classification of Diseases, 9th revision; NCHS  National Center for Health Statistics; ROC  Resuscitation Outcomes Consortium; other abbreviations as in Table 1.
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in the U.S. population remains unclear.
The widely ranging estimates published in the few studies
that have tackled this question highlight the lack of clarity
about the true annual incidence of SCA and/or SCD in the
U.S. By extension, discrepancies in published estimates
reflect inconsistencies in the medical community’s knowl-
edge and understanding of SCD.
Multiple and sometimes discordant case definitions are
used to describe SCA, which is often incorrectly used
interchangeably with SCD in the literature. To date, there
is no standardized, universal definition used uniformly
across the large numbers of studies of this clinical entity.
Confusion surrounding the definition of “sudden cardiac
death” starts with the fundamentally complex nature of the
entity we are attempting to capture within the constraints of
the English lexicon, namely, what counts as “sudden”?
What qualifies as “cardiac”? Do “sudden” and “cardiac” refer
to “death” and/or “resuscitated death”? These definitional
issues have been recognized, and numerous definitions have
been put forth over the last half century; however, no single,
“all-purpose” definition has emerged in light of the myriad,
often multifactorial, etiologies of SCD (25,26). Rather than
propose a universal definition of SCD, the World Health
Organization Scientific Group on SCD wrote in 1985 that
Additional Sources Cited by the ACC/AHA/ESC 2006 Guidelines foof Patients With Ventricular Arrhythmias and the Prevent on of SudTable 3 Additio al Sou ces Ci ed by the A C/AHA/ESC 2006of Patients With Ventricular Arrhythmias and the Preve
Source (Ref. #)
Definitional Equivalents
of SCA or SCD
Estimated In
of SCD (No P
Data Prese
Myerburg et al. (2) SCD defined as “cardiovascular
deaths that are sudden and
unexpected.”
300,00
AHA Heart Disease and
Stroke (21)
SCD  sudden cardiac death, defined
as “sudden cardiac deaths from
coronary disease.”
335,00
*No primary data presented in publication.
ACC  American College of Cardiology; AHA  American Heart Association; ESC  European S
Measure of Impact and Data DisseminationTable 4 Measure of Impact and Data Dissemination
Source, Year (Ref. #)
Number of Citations Found by Web of
Science Cited Reference Search
(Dates of Publications Citing Each Reference)
Sources with estimate derived from primary data
Gillum, 1989 (14) 197 (January 1990–November 2009)
Escobedo et al., 1996 (15) 59 (April 1997–September 2009)
Zheng et al., 2001 (18) 400 (March 2002–November 2009)
Cobb et al., 2002 (16) 161 (December 2002–November 2009)
Chugh et al., 2004 (17) 74 (January 2005–November 2009)
Chugh et al., 2008 (20) 9 (June 2009–November 2009)
Nichol et al., 2008 (19) 67 (September 2008–April 2010)
Sources with estimates not derived from primary data,
but cited by the 2006 ACC/AHA/ESC guidelines
Myerburg et al., 1993 (2) 207 (December 1993–December 2009)
AHA heart disease and stroke,
2004 (21)
Not availableAbbreviations as in Table 3.it is “more meaningful to define the specific characteristics
surrounding cardiac arrest, and register and collect data in a
standardized way, than to try to define the word ‘sudden’ in
the context of death” (25). According to the ACC/AHA/
ESC 2006 guidelines, SCA is defined as “death from an
unexpected circulatory arrest, usually due to a cardiac
arrhythmia occurring within an hour of the onset of symp-
toms, in whom medical intervention (e.g., defibrillation)
reverses the event” (12); and SCD is defined as “death from
an unexpected circulatory arrest, usually due to a cardiac
arrhythmia occurring within an hour of the onset of symp-
toms” (12).
There are a number of possible reasons that the annual
incidence of SCA and/or SCD in the U.S. remains unclear.
To begin, there are few studies focused on answering this
question, and among this handful of studies, most are old,
dependent on death certificate data, and not prospective.
Across studies there was significant variation in case defi-
nitions of SCD and methods of case ascertainment.
Instead of prospective case ascertainment, most of the
available estimates are based on retrospective death
certificate-based methodology. Death certificate data do not
account for survived SCA and have been demonstrated in
validation studies to overestimate the incidence of SCD
(27–29). The study providing the highest estimate of annual
SCD incidence (450,000) used only death certificate-
based retrospective surveillance (18) compared with the
more recent prospective study that provides a range that
included the lowest estimate (180,000 to 250,000) and
employed multiple methods of case ascertainment (17).
Additional difficulties stemming from these estimates’ de-
pendence on death certificate data are the lack of uniform
designation of cause of death on the certificate (30). On
death certificates, SCD is often listed as the primary cause
of death even when the patient had multiple comorbidities
that may have directly contributed to death. Like death
certificate data, other sources of retrospective case ascertain-
ment such as vital statistics and census data also misclassify
and can overestimate SCD (30). Finally, the prospective,
community-based studies, used data from first-responders,
which results in the inherent exclusion of unwitnessed SCA
nagementC rdiac Deathlines for Management
of Sudden Cardiac Death
e
y
Sources for Estimate
Publication
Date
1. Reported “estimates are based on published epidemiologic
and clinical data” with 2 citations: Myerburg (23) and
Myerburg (24).
1993
1. Only sources listed are ICD-9 codes 427.4 and
ICD-10 code I49.0*
2004
f Cardiology; other abbreviations as in Tables 1 and 2.r MadenGuide
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Incidence of Sudden Death in the U.S. February 15, 2011:794–801From a public health perspective, the ability to reliably
estimate the incidence of SCA and/or SCD in the U.S. is
important because it informs our efforts to prevent SCD, to
improve risk stratification techniques, and to direct future
research that may save lives. On the basis of our findings
from this review of the literature, we recommend 3 action-
able next steps toward addressing our knowledge and data
gaps:
1. Establish precise, uniform definitions of SCA and of
SCD, to be agreed upon and adopted by the major
stakeholders in the medical/scientific community. SCA
and SCD should have 2 distinct definitions that should
not be used interchangeably, as SCA includes a subset of
potentially lethal events that are reversed with medical
intervention. We support the definitions put forth by the
ACC/AHA/ESC 2006 guidelines that state: 1) sudden
cardiac arrest is “an unexpected circulatory arrest, usually
due to a cardiac arrhythmia occurring within an hour of the
onset of symptoms, in whom medical intervention (e.g.,
defibrillation) reverses the event” (12); and 2) sudden
cardiac death is “death from an unexpected circulatory
arrest, usually due to a cardiac arrhythmia occurring
within an hour of the onset of symptoms” (12).
. Perform larger, multicenter, prospective studies in the
general population as well as across different geographic
regions and races, using the above definitions to facilitate
optimal case ascertainment. The Resuscitation Out-
comes Consortium (ROC) is a clinical research network
of 11 sites and 1 central coordinating center in addition
to its companion prospective, multicenter, observational
registry of the 11 sites (ROC Epistry-Cardiac Arrest)
established to evaluate out-of-hospital cardiac arrest and
resuscitation outcomes in the participating geographic
regions (19). One potential approach for achieving more
reliable national estimates of SCA and SCD could be
based on an expansion of the ROC and ROC-ECA
design, establishing a national SCA and SCD research
network composed of 40 to 50 emergency medical
services agencies with a central receiving institution
selected to be nationally representative.
. Integrate multiple source methods for case ascertainment
to capture more cases and rule out those cases that do not
meet strict criteria according to the definitions deter-
mined above. Using multiple sources to confirm cases of
SCA and/or SCD will help to minimize dependence on
death certificate data.
It is hoped this initial framework will help to put in place
he necessary elements enabling us to fill in data gaps on this
mportant public health issue. Establishing definitional
greement in the medical community and in the literature
ill facilitate the more reliable evaluation and comparisons
f therapies, utilization, and outcomes, which will ulti-
ately enhance our strategies for risk stratification and
revention of SCD. Given the paucity of studies providing
urrent data on the annual incidence of SCD in the U.S.,these findings highlight the need for additional contempo-
raneous studies to be performed prospectively and to inte-
grate multiple methods of case ascertainment to determine
the true incidence of SCD in the U.S. Consideration should
be given to create a national surveillance system to assess the
characteristics, treatments, and outcomes of patients with
SCA; facilitate efforts to improve the quality of resuscitation
and SCA patient care; and implement research findings and
evidence-based recommendations into clinical practice.
Conclusions
The true incidence of SCA and/or SCD in the U.S. remains
unclear, with a wide range in available estimates. To
advance knowledge and understanding of the epidemiology
of SCD and improve risk stratification and prevention, there
needs to be a focused effort to create a standard definition of
both SCA and SCD and to expand national research efforts
to precisely capture cases of SCA and SCD prospectively
and more broadly across communities.
Reprint requests and correspondence: Dr. Melissa H. Kong,
Duke University Medical Center, DUMC Box 31294, Durham,
North Carolina 27710. E-mail: kong0017@mc.duke.edu.
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APPENDIX
For a list of participants in the SCATLA meeting and recent participants in
Duke’s Center for the Prevention of Sudden Cardiac Death, please see the
online version of this article.
